Original Article

You have full text access to this OnlineOpen article

Mammographic screening reduces risk of breast carcinoma recurrence

  1. Pirjo Immonen-Räihä M.D., Ph.D.1,†,*,
  2. Lea Kauhava M.Sc.2,
  3. Ilmo Parvinen M.D.3,
  4. Kaija Holli M.D., Ph.D.4,
  5. Pauliina Kronqvist M.D., Ph.D.5,
  6. Liisa Pylkkänen M.D., Ph.D.6,
  7. Hans Helenius M.Sc.7,
  8. Anne Kaljonen B.Sc.8,
  9. Osmo Räsänen M.D.9,
  10. Pekka J. Klemi M.D., Ph.D.5

Article first published online: 20 DEC 2004

DOI: 10.1002/cncr.20793

Issue

Cancer

Cancer

Volume 103, Issue 3, pages 474–482, 1 February 2005

Additional Information

How to Cite

Immonen-Räihä, P., Kauhava, L., Parvinen, I., Holli, K., Kronqvist, P., Pylkkänen, L., Helenius, H., Kaljonen, A., Räsänen, O. and Klemi, P. J. (2005), Mammographic screening reduces risk of breast carcinoma recurrence. Cancer, 103: 474–482. doi: 10.1002/cncr.20793

Author Information

  1. 1

    Department of Internal Medicine, University Hospital, University of Turku, Turku, Finland

  2. 2

    Health Office of the City of Turku, Turku, Finland

  3. 3

    Finnish National Fund for Research and Development, Helsinki, Finland

  4. 4

    Department of Palliative Medicine, University Hospital, University of Tampere, Finland

  5. 5

    Department of Pathology, University Hospital, University of Turku, Turku, Finland

  6. 6

    Department of Oncology, University Hospital, University of Turku, Turku, Finland

  7. 7

    Department of Biostatistics, University of Turku, Turku, Finland

  8. 8

    Department of Psychiatry, University of Turku, Turku, Finland

  9. 9

    Cancer Society of Southwest Finland, Turku, Finland

  1. †

    Fax: (011) 358 2 3138573

*Department of Internal Medicine, Turku University Hospital, POB 43, FIN-21201 Raisio, Finland

Publication History

  1. Issue published online: 20 JAN 2005
  2. Article first published online: 20 DEC 2004
  3. Manuscript Accepted: 7 OCT 2004
  4. Manuscript Revised: 1 OCT 2004
  5. Manuscript Received: 17 MAY 2004

Funded by

  • Ministry of Social Affairs and Health
  • Foundation for Economic Education (Sameli Männistö Fund)
  • Finnish Cancer Organizations
  • Cancer Society of Southwest Finland

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (126K)

REFERENCES

  • 1
    Shapiro S, Coleman EA, Broeders M, et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol. 1998; 27: 735–742.
  • 2
    Hakama M, Pukkala E, Heikkilä M, Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland: population-based cohort study. BMJ. 1997; 314: 864–867.
  • 3
    Klemi PJ, Parvinen I, Pylkkänen L, et al. Significant improvement in breast cancer survival through population-based mammography screening. Breast. 2003; 12: 308–313.
  • 4
    Rosner D, Lane WW. Predicting recurrence in axillary-node negative breast cancer patients. Breast Cancer Res Treat. 1993; 25: 127–139.
  • 5
    Arriagada R, Le MG, Contesso G, Guinebretiere JM, Rochard F, Spielmann M. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol. 2002; 13: 1404–1413.
  • 6
    Warwick J, Tabar L, Vitak B, Duffy SW. Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County study. Cancer. 2004; 100: 1331–1336.
    Direct Link:
  • 7
    Kauhava L, Immonen-Räihä P, Parvinen I, et al. Lower costs of hospital treatment of breast cancer through a population-based mammography screening programme. Eur J Public Health. 2004; 14: 128–133.
  • 8
    Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002; 359: 909–919.
  • 9
    Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137: 347–360.
  • 10
    VainioH, BianchiniF, editors. IARC handbooks of cancer prevention: breast cancer screening. Volume 7. Lyon: IARC Press, 2002.
  • 11
    Duffy SW, Tabár L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer. 2002; 95: 458–469.
    Direct Link:
  • 12
    Kronqvist P, Kuopio T, Nykänen M, Helenius H, Anttinen J, Klemi P. Predicting aggressive outcome in T1N0M0 breast cancer. Br J Cancer. 2004; 91: 277–281.
  • 13
    Olivotto IA, Mates D, Kan L, Fung J, Samant R, Burhenne LJ. Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia. Breast Cancer Res Treat. 1999; 54: 73–81.
  • 14
    Magee B, Stewart AL, Swindell R. Outcome of radiotherapy after breast conserving surgery in screen detected breast cancers. Clin Oncol. 1999; 11: 40–45.
  • 15
    Immonen-Räihä P, Kauhava L, Parvinen I, Helenius H, Klemi P. Customer fee and participation in breast-cancer screening. Lancet. 2001; 358: 1425.
  • 16
    Klemi PJ, Toikkanen S, Räsänen O, Parvinen I, Joensuu H. Mammography screening interval and the frequency of interval cancers in a population-based screening. Br J Cancer. 1997; 75: 762–766.
  • 17
    HermanekP, SobinLH, editors. UICC TNM classification of malignant tumours (4th edition). Berlin: Springer-Verlag, 1987.
  • 18
    Finnish Breast Cancer Group. Rintasyövän valtakunnallinen diagnostiikka- ja hoitosuositus (3rd edition) [National guidelines for diagnosis and treatment of breast cancer]. Kuopio: Finnish Breast Cancer Group, 1999.
  • 19
    Porter PL, El-Bastawissi AY, Mandelson MT, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999; 91: 2020–2028.
  • 20
    Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003; 289: 1421–1424.
  • 21
    Daling JR, Malone KE, Doody DR, et al. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer. 2002; 95: 2455–2464.
    Direct Link:
  • 22
    Holli K, Isola J, Cuzick J. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J Clin Oncol. 1998; 16: 3115–3120.
  • 23
    Schairer C, Gail M, Byrne C, et al. Estrogen replacement therapy and breast cancer survival in a large screening study. J Natl Cancer Inst. 1999; 91: 264–270.
  • 24
    Willis DB, Calle EE, Miracle-McMahill HL, Heath WW Jr. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States. Cancer Causes Control. 1996; 7: 449–457.
  • 25
    Cuzick J. Is hormone replacement therapy safe for breast cancer patients? J Natl Cancer Inst. 2001: 93; 733–734.
  • 26
    Salmi T, Paldán M, Klaukka T. Vaihdevuosihormonien käyttö on vähentynyt maan kaikissa osissa*lsqb;The use of hormone replacement therapy has decreased in all parts of Finland]. Suomen Laakarilehti. 2004; 59: 1042–1045.
  • 27
    Aro AR, de Koning HJ, Absetz P, Schreck M. Two distinct groups of non-attenders in an organized mammography screening program. Breast Cancer Res Treat. 2001; 70: 145–153.
View Full Article (HTML) Get PDF (126K)